WuXi STA: acquisition of former Bristol Myers Squibb facility
WuXi STA has wrapped its acquisition of a drug product manufacturing facility in Couvet, Switzerland. The tablet and capsule manufacturing and packaging facility is WuXi STA’s first facility in Europe.
Minzhang Chen, co-CEO of parent company WuXi AppTec, said, “Through combining resources of the Couvet site with our other facilities, we continue strengthening and broadening our capacity and capabilities to better support our global customers in delivering innovative medicines to patients in need.”
